Skip to main content

Autologous Stem Cell Seeded Tissue Engineered Trachea

Objective

CLINICAL PROBLEM AND UNMET NEED
There are 11,827 patients with severe structural airway disease in Europe. Even with the current standard of care, when hospitalised this group of patients has a 22% risk of dying. Patients are currently subjected to repeated surgical interventions (stent insertion) which have a high failure rate.

Other therapeutic strategies under development include synthetic tracheal scaffolds seeded with patients own stem cells. Preliminary data show that these scaffolds are poorly integrated and are susceptible to infection.

TETRA PROJECT
Our SME-led project will address the limitations of standard clinical care and competitor products under development and will:
- Build on our successful compassionate use experience using autologous stem cell seeded scaffold-tracheal transplants in 48 patients
- Follow on from our Phase I 4 patient INSPIRE clinical trial which will improve on the clinical prototype used in compassionate use cases
- Conduct a 48 patient Phase II pivotal clinical trial to provide robust, quality data with validated GMP manufacturing processes to support an accelerated route to market for commercial exploitation in this orphan indication
- Prepare a dossier for MAA submission

BENEFITS
Our product, an ATMP, aims to eliminate the need for repeated surgical interventions of high risk and limited efficacy, reduce deaths and improve the quality of life for surviving patients. If treating 20% of the patients with severe structural airway disease, we estimate that in Europe our technology will improve the quality and length of patient lives and result in savings of €517 million per year.

We plan to further develop our platform technology to generate other complex tissues/organs such as bowel and liver replacements for clinical applications which will impact the lives of tens of thousands of patient in the EU with bowel and liver diseases.

Field of science

  • /medical and health sciences/medical biotechnology/cells technologies/stem cells

Call for proposal

H2020-PHC-2015-single-stage_RTD
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

VIDEREGEN LIMITED
Address
Innovation Centre 1, Liverpool Science Park, 131 M Ant
L3 5TF Liverpool
United Kingdom
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 563 340,80

Participants (12)

EURAM LIMITED

Participation ended

United Kingdom
EU contribution
€ 65 496,20
Address
Lucy Tower Street Tower House
LN1 1XW Lincoln
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
CELL THERAPY CATAPULT LIMITED
United Kingdom
EU contribution
€ 281 681
Address
12Th Floor Tower Wing Guy's Hospital Great Maze Pond
SE1 9RT London
Activity type
Research Organisations
TMC PHARMA SERVICES LIMITED
United Kingdom
EU contribution
€ 1 127 146
Address
Lodge Farm Barn, Elvetham Park Estate
RG27 8AS Hartley Wintney
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
NHS BLOOD AND TRANSPLANT
United Kingdom
EU contribution
€ 535 250
Address
Oak House Reeds Crescent
WD24 4QN Watford
Activity type
Research Organisations
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Germany
EU contribution
€ 903 250
Address
Ismaninger Strasse 22
81675 Muenchen
Activity type
Higher or Secondary Education Establishments
UNIVERSITY COLLEGE LONDON
United Kingdom
EU contribution
€ 455 118
Address
Gower Street
WC1E 6BT London
Activity type
Higher or Secondary Education Establishments
UNIVERSITY COLLEGE LONDON HOSPITALSNHS FOUNDATION TRUST
United Kingdom
EU contribution
€ 669 578
Address
Euston Road 250
NW1 2PG London
Activity type
Research Organisations
UNIVERSITA DEGLI STUDI DI BRESCIA
Italy
EU contribution
€ 346 266
Address
Piazza Mercato 15
25121 Brescia
Activity type
Higher or Secondary Education Establishments
MEDIZINISCHE UNIVERSITAET WIEN

Participation ended

Austria
EU contribution
€ 2 546
Address
Spitalgasse 23
1090 Wien
Activity type
Higher or Secondary Education Establishments
INSTYTUT GRUZLICY I CHOROB PLUC
Poland
EU contribution
€ 365 000
Address
Ul. Plocka 26
01138 Warszawa
Activity type
Research Organisations
THE UNIVERSITY OF MANCHESTER
United Kingdom
EU contribution
€ 30 700
Address
Oxford Road
M13 9PL Manchester
Activity type
Higher or Secondary Education Establishments
MANCHESTER UNIVERSITY NHS FOUNDATION TRUST
United Kingdom
EU contribution
€ 483 512
Address
Oxford Road
M13 9WL Manchester
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)